The Narc & Dangerous Drugs Control agency is tasked with enforcing state-level controls over controlled substances and combating illicit drug trafficking through targeted procurement of pharmaceutical supply chain services. Its procurement activity centers on the distribution and wholesale logistics...
The Narc & Dangerous Drugs Control agency is tasked with enforcing state-level controls over controlled substances and combating illicit drug trafficking through targeted procurement of pharmaceutical supply chain services. Its procurement activity centers on the distribution and wholesale logistics of regulated pharmaceuticals and related sundries, indicating a primary focus on securing lawful access to controlled medications while preventing diversion. Strategic priorities include maintaining the integrity of the pharmaceutical supply chain, ensuring compliance with state and federal drug control regulations, and supporting law enforcement and regulatory operations with reliable, auditable sourcing mechanisms. Key programs likely involve monitoring prescription drug distribution networks, supporting forensic toxicology operations, and enabling interagency coordination through secure pharmaceutical logistics.
The agency’s procurement patterns are narrowly focused on merchant wholesale distribution of drugs and druggists’ sundries, as evidenced by its sole dominant NAICS code, 424210. This suggests a reliance on established pharmaceutical wholesalers to procure legally compliant substances, ancillary medical supplies, and controlled substance packaging or tracking materials. Contracts are typically awarded through standard government solicitation processes without set-asides, indicating a preference for established commercial distributors with proven regulatory adherence rather than niche or emerging vendors.
Industry preferences are heavily concentrated in the wholesale pharmaceutical distribution sector, with no discernible emphasis on small business, minority-owned, or other diversity-focused set-asides. Vendor relationships appear transactional and compliance-driven, prioritizing entities with DEA registration, GSP certification, and robust chain-of-custody protocols. The agency does not appear to engage in R&D, technology integration, or digital platform procurement, reinforcing its operational role as a regulatory and logistical enforcer rather than an innovator.
Organized under the Oklahoma Department of Public Safety, the agency operates statewide with no localized subdivisions indicated. It utilizes standard federal and state procurement vehicles for commercial goods, relying on competitive solicitation and direct purchase authority for regulated pharmaceuticals. Its structure reflects a law enforcement and regulatory mandate, with procurement aligned strictly to operational compliance needs.
